Therefore, the pIX-modified Ad5 vector may have enhanced tumor targeting by mediating TRAIL binding to specific receptor moieties on the cancer cell surface, and liver enrichment of the virus may be reduced due to steric hindrance of the hexon–FX binding during IV administration. The gene discussed is F10; the disease is cancer.